spacer
home > pmps > summer 2019 > planning your automation project
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Planning Your Automation Project

At the end of 2018, the Medicines and Healthcare products Regulatory Agency undertook a pharmacy-level recall of several batches of blood pressure and heart medication (valsartancontaining medicines) made by Mylan and Teva. This followed previous action across Europe recalling the same substance from Dexcel and Actavis. The precautionary measure was put in place to prevent any risk to patient safety after an impurity was identified as part of the manufacturing process.

When the stakes of manufacturing are so high, it is only natural to want to stick with tried and tested methods. Any issues that occur during the manufacturing process can have a significant impact on drug supply and patient care; for example, patients cannot just stop taking their blood pressure and heart medication.

However, incorporating automation equipment and software into the production line can lead to myriad benefits. A more robust, modern manufacturing approach can lead to fewer interruptions, fewer product failures, and greater confidence that drugs will meet clinical performance. While industries like automotive and aerospace have excelled in automation, many pharmaceutical companies are concerned that the technology is too complex a change.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Marketing Director by day, Jonathan Wilkins is also one of the most prolific Industry 4.0 writers in the industrial automation sector. A professional brand advocate and commercial marketing strategist, Jonathan has been part of the EU Automation team since its humble beginnings in 2009 and has over a decade of experience in marketing.
spacer
Jonathan Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sartorius Stedim Biotech Launches New Services for Mammalian Cell Bank Manufacturing

GOETTINGEN, Germany and GLASGOW, UK, August 08, 2019 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions. These services are offered by its subsidiary, Sartorius Stedim BioOutsource, an experienced contract testing organization (CTO) based in Glasgow, UK, and in Cambridge, Massachusetts, USA.
More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). Its about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

 
Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th 12th May 2020. HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement